20/20 Biolabs OneTest for Vermont Firefighters; $500K Revenue Expected
20/20 Biolabs' OneTest multi-cancer early detection blood test has been selected for a firefighter cancer screening initiative in Vermont, partnering with National Diagnostic Services. This 12-month statewide program is anticipated to generate approximately $500,000 in testing revenues for 20/20 Biolabs from the first cohort of Vermont firefighters through the end of 2026, with options for renewal. This follows a successful program in Maryland, which is expected to generate over $500,000 this quarter, with over $400,000 reimbursed by the Maryland Department of Health. The company anticipates more states will establish similar dedicated funds for firefighter screening and expects to benefit from future Medicare coverage for MCEDs starting in 2028.
Key Highlights
- OneTest selected for Vermont firefighter cancer screening initiative in partnership with NDS.
- Vermont program expected to generate approximately $500,000 in testing revenues for 20/20 Biolabs.
- Vermont contract includes options for up to two additional 12-month renewal periods.
- Company expects to process over $500,000 of OneTests from Maryland fire departments this quarter.
- Over $400,000 of Maryland revenue is reimbursed by the Maryland Department of Health.
- Maryland state-funded revenue increased significantly from $105,000 in the prior year.
- Legislation passed in February 2026 establishes Medicare coverage pathway for MCEDs starting 2028.
Price Impact
More from AIDX